Michael N Diringer, MD

Head of the Neurological Critical Care Section—Adult Neurology; Professor of Neurology

Phone314-362-2999

Fax314-362-0215

Emaildiringerm@neuro.wustl.edu

Additional Titles

  • Director, Neurology-Neurosurgery ICU (NNICU) at Barnes-Jewish Hospital
  • Professor, Neurosurgery
  • Associate Professor, Anesthesiology
  • Associate Professor, Occupational Therapy

Board Certifications

  • Neurology

Related Links

Recognition

  • Listed in Best Doctors in America, 1998-2013 (Best Doctors, Inc.)
  • Presidential Citation, Society for Critical Care Medicine, 2003

Publications

  • Rubin MA, Dhar R, Diringer MN. Racial differences in withdrawal of mechanical ventilation do not alter mortality in neurologically injured patients. J Crit Care. 2014 Feb;29(1):49-53.
  • Raya A, Zipfel GJ, Diringer MN, Dacey RG Jr, Derdeyn CP, Rich KM, Chicoine MR, Dhar R. Pattern not volume of bleeding predicts angiographic vasospasm in nonaneurysmal subarachnoid hemorrhage. Stroke. 2014 Jan;45(1):265-7.
  • Kumar A, Brown R, Dhar R, Sampson T, Derdeyn CP, Moran CJ, Diringer MN. Early vs. delayed cerebral infarction after aneurysm repair after subarachnoid hemorrhage. Neurosurgery. 2013 Oct;73(4):617-23; discussion 623.
  • Diringer MN. Controversy: does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome? Stroke. 2013 Jun;44(6 Suppl 1):S29-30.
  • Brown RJ, Kumar A, Dhar R, Sampson TR, Diringer MN. The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2013 May;72(5):702-7; discussion 707-8.
  • Diringer MN. New trends in hyperosmolar therapy? Curr Opin Crit Care. 2013 Apr;19(2):77-82.
  • Keyrouz SG, Diringer MN. Year in review 2011: Critical Care – neurocritical care. Crit Care. 2012 Dec 10;16(6):245. [Epub ahead of print]
  • Scalfani MT, Dhar R, Zazulia AR, Videen TO, Diringer MN. Effect of osmotic agents on regional cerebral blood flow in traumatic brain injury. J Crit Care. 2012 Oct;27(5):526.e7-12.
  • Diringer MN, Zazulia AR. Hemostatic therapy should be used for acute treatment of anticoagulation-related intracerebral hemorrhage. Stroke. 2012 Sep;43(9):2535-6.
  • Delgado Almandoz JE, Jagadeesan BD, Refai D, Moran CJ, Cross DT 3rd, Chicoine MR, Rich KM, Diringer MN, Dacey RG Jr, Derdeyn CP, Zipfel GJ. Diagnostic yield of computed tomography angiography and magnetic resonance angiography in patients with catheter angiography-negative subarachnoid hemorrhage. J Neurosurg. 2012 Aug;117(2):309-15.
  • Diringer MN, Scalfani MT, Zazulia AR, Videen TO, Dhar R, Powers WJ. Effect of mannitol on cerebral blood volume in patients with head injury. Neurosurgery. 2012 May;70(5):1215-8; discussion 1219.
  • Dhar R, Scalfani MT, Zazulia AR, Videen TO, Derdeyn CP, Diringer MN. Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage. J Neurosurg. 2012 Mar;116(3):648-56.
  • Scalfani MT, Diringer MN. Year in review 2010: Critical Care–Neurocritical care. Crit Care. 2011;15(6):237.
  • Diringer MN, Zazulia AR, Powers WJ. Does Ischemia Contribute to Energy Failure in Severe TBI? Transl Stroke Res. 2011 Dec;2(4):517-23.

Dr. Diringer is the Director of the Neurology-Neurosurgery Intensive Care Unit and Head of the Neurological Critical Care Section.

Dr. Diringer is a fellow of the American Heart Association (Stroke) and the American College of Critical Care Medicine. He has been repeatedly listed as one of the “Best Doctor’s in America” and “Best Doctor’s in St. Louis.” In 2004 Dr. Diringer was installed as the president of the Neurocritical Care Society.

The Neurology/Neurosurgery Intensive Care Unit serves as our “clinical laboratory.” It is the only unit of its type in the U.S. with on-site PET scanning facilities. The goal of our research efforts is to improve the quality of care delivered to critically ill patients with neurological and neurosurgical disease by focusing on the impact of therapeutic regimes on cerebrovascular hemodynamics and metabolism. It is our hope to settle some of the major controversies presently surrounding the treatment of our patients. These include such therapies as hyperventilation, manipulating blood pressure and the use of osmotic agents.